PDCD5 interacts with p53 and functions as a positive regulator in the p53 pathway

Apoptosis

Volumn 17, Issue 11, 2012, Pages 1235-1245

  Xu, Lanjun ^a,b   Hu, Jing ^a,b   Zhao, Yuanbo ^a,b   Hu, Jia ^c   Xiao, Juan ^a,b   Wang, Yanming ^c   Ma, Dalong ^a,b   Chen, Yingyu ^a,b  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b PEKING UNIVERSITY   (China)

^c PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

Cell cycle; Mdm2; p21; p53; PDCD5

Indexed keywords

ACTIN; APOPTOSIS REGULATORY PROTEIN; GLUTATHIONE TRANSFERASE; PROTEASOME; PROTEIN MDM2; PROTEIN P21; PROTEIN P53; PROTEIN PDCD5; SERINE; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA DAMAGE; GENE; HELA CELL; P21 GENE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; UPREGULATION;

ACTIVE TRANSPORT, CELL NUCLEUS; APOPTOSIS REGULATORY PROTEINS; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA DAMAGE; G1 PHASE CELL CYCLE CHECKPOINTS; GENE KNOCKDOWN TECHNIQUES; HUMANS; MODELS, BIOLOGICAL; NEOPLASM PROTEINS; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN STABILITY; PROTEIN TRANSPORT; PROTEOLYSIS; PROTO-ONCOGENE PROTEINS C-MDM2; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53; UBIQUITINATION;

EID: 84868089289     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-012-0754-x     Document Type: Article

References (43)

1. Hollstein M, Sidransky D, Vogelstein B, Harris CC (1991) p53 mutations in human cancers. Science 253:49-53 (Pubitemid 21917115)
2. Laptenko O, Prives C (2006) Transcriptional regulation by p53: one protein, many possibilities. Cell Death Differ 13:951-961
3. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57-70 (Pubitemid 30046295)
4. Mihara M, Erster S, Zaika A et al (2003) p53 has a direct apoptogenic role at the mitochondria. Mol Cell 11:577-590 (Pubitemid 36385115)
5. Kubbutat MH, Jones SN, Vousden KH (1997) Regulation of p53 stability by Mdm2. Nature 387:299-303 (Pubitemid 27220767)
6. Leng RP, Lin Y, Ma W et al (2003) Pirh2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation. Cell 112:779-791 (Pubitemid 36378882)
7. Dornan D, Wertz I, Shimizu H et al (2004) The ubiquitin ligase COP1 is a critical negative regulator of p53. Nature 429:86-92 (Pubitemid 38620556)
8. Chen D, Kon N, Li M et al (2005) ARF-BP1/Mule is a critical mediator of the ARF tumor suppressor. Cell 121:1071-1083 (Pubitemid 40884397)
9. Brady CA, Jiang D, Mello SS et al (2011) Distinct p53 transcriptional programs dictate acute DNA-damage responses and tumor suppression. Cell 145:571-583
10. Bode AM, Dong Z (2004) Post-translational modification of p53 in tumorigenesis. Nat Rev Cancer 4:793-805 (Pubitemid 39331151)
11. Higashimoto Y, Saito S, Tong XH et al (2000) Human p53 is phosphorylated on serines 6 and 9 in response to DNA damageinducing agents. J Biol Chem 275:23199-23203 (Pubitemid 30646216)
12. Sakaguchi K, Saito S, Higashimoto Y et al (2000) Damagemediated phosphorylation of human p53 threonine 18 through a cascade mediated by a casein 1-like kinase. Effect on Mdm2 binding. J Biol Chem 275:9278-9283 (Pubitemid 30185148)
13. Abraham RT (2001) Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes Dev 15:2177-2196 (Pubitemid 32843830)
14. Banin S, Moyal L, Shieh S et al (1998) Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science 281:1674-1677
15. Tibbetts RS, Brumbaugh KM, Williams JM et al (1999) A role for ATR in the DNA damage-induced phosphorylation of p53. Genes Dev 13:152-157 (Pubitemid 29061945)
16. Hirao A, Kong YY, Matsuoka S et al (2000) DNA damageinduced activation of p53 by the checkpoint kinase Chk2. Science 287:1824-1827
17. Shieh SY, Ikeda M, Taya Y, Prives C (1997) DNA damageinduced phosphorylation of p53 alleviates inhibition by MDM2. Cell 91:325-334 (Pubitemid 27467963)
18. Lu H, Fisher RP, Bailey P, Levine AJ (1997) The CDK7-cycHp36 complex of transcription factor IIH phosphorylates p53, enhancing its sequence-specific DNA binding activity in vitro. Mol Cell Biol 17:5923-5934 (Pubitemid 27411099)
19. Liu H, Wang Y, Zhang Y et al (1999) TFAR19, a novel apoptosis-related gene cloned from human leukemia cell line TF-1, could enhance apoptosis of some tumor cells induced by growth factor withdrawal. Biochem Biophys Res Commun 254:203-210 (Pubitemid 29292042)
20. Wang Y, Li X, Wang L et al (2004) An alternative form of paraptosis-like cell death, triggered by TAJ/TROY and enhanced by PDCD5 overexpression. J Cell Sci 117:1525-1532 (Pubitemid 38559827)
21. Chen Y, Sun R, Han W et al (2001) Nuclear translocation of PDCD5 (TFAR19): an early signal for apoptosis? FEBS Lett 509:191-196 (Pubitemid 34015941)
22. Spinola M, Meyer P, Kammerer S et al (2006) Association of the PDCD5 locus with lung cancer risk and prognosis in smokers. J Clin Oncol 24:1672-1678 (Pubitemid 46622138)
23. Yang Y, Zhao M, Li W et al (2006) Expression of programmed cell death 5 gene involves in regulation of apoptosis in gastric tumor cells. Apoptosis 11:993-1001 (Pubitemid 43876829)
24. Ruan G, Qin Y, Chen S et al (2006) Abnormal expression of the programmed cell death 5 gene in acute and chronic myeloid leukemia. Leuk Res 30:1159-1165 (Pubitemid 44037086)
25. Du Y, Xiong L, Lou Y, Tan W, Zheng S (2009) Reduced expression of programmed cell death 5 protein in tissue of human prostate cancer. Chin Med Sci J 24:241-245
26. Zhang X, Wang X, Song X et al (2011) Clinical and prognostic significance of lost or decreased PDCD5 expression in human epithelial ovarian carcinomas. Oncol Rep 25:353-358
27. Li H, Wang Q, Gao F et al (2008) Reduced expression of PDCD5 is associated with high-grade astrocytic gliomas. Oncol Rep 20:573-579
28. Chen C, Zhou H, Xu L et al (2010) Prognostic significance of downregulated expression of programmed cell death 5 in chondrosarcoma. J Surg Oncol 102:838-843
29. Ruan G, Zhao H, Chang Y et al (2008) Adenovirus-mediated PDCD5 gene transfer sensitizes K562 cells to apoptosis induced by idarubicin in vitro and in vivo. Apoptosis 13:641-648
30. Chen C, Zhou H, Xu L et al (2010) Recombinant human PDCD5 sensitizes chondrosarcomas to cisplatin chemotherapy in vitro and in vivo. Apoptosis 15:805-813
31. Shi L, Song Q, Zhang Y et al (2010) Potent antitumor activities of recombinant human PDCD5 protein in combination with chemotherapy drugs in K562 cells. Biochem Biophys Res Commun 396:224-230
32. Wang Y, Song Q, Zhang Y et al (2009) Recombinant human PDCD5 protein enhances chemosensitivities of hematologic malignancies. Chin Sci Bull 54:3981-3989
33. Ma X, Ruan G, Wang Y et al (2005) Two single-nucleotide polymorphisms with linkage disequilibrium in the human programmed cell death 5 gene 50 regulatory region affect promoter activity and the susceptibility of chronic myelogenous leukemia in Chinese population. Clin Cancer Res 11:8592-8599 (Pubitemid 43005905)
34. Xu L, Chen Y, Song Q et al (2009) PDCD5 interacts with Tip60 and functions as a cooperator in acetyltransferase activity and DNA damage-induced apoptosis. Neoplasia 11:345-354
35. Chen L, Wang Y, Ma D, Chen Y (2006) Short interfering RNA against the PDCD5 attenuates cell apoptosis and caspase-3 activity induced by Bax overexpression. Apoptosis 11:101-111 (Pubitemid 43151648)
36. Li P, Wang D, Yao H et al (2010) Coordination of PAD4 and HDAC2 in the regulation of p53-target gene expression. Oncogene 29:3153-3162
37. Chen D, Zhang Z, Li M et al (2007) Ribosomal protein S7 as a novel modulator of p53-MDM2 interaction: binding to MDM2, stabilization of p53 protein, and activation of p53 function. Oncogene 26:5029-5037 (Pubitemid 47206956)
38. Dai MS, Lu H (2004) Inhibition of MDM2-mediated p53 ubiquitination and degradation by ribosomal protein L5. J Biol Chem 279:44475-44482 (Pubitemid 39430853)
39. Jin A, Itahana K, O'Keefe K, Zhang Y (2004) Inhibition of HDM2 and activation of p53 by ribosomal protein L23. Mol Cell Biol 24:7669-7680 (Pubitemid 39121492)
40. Lohrum MA, Ludwig RL, Kubbutat MH, Hanlon M, Vousden KH (2003) Regulation of HDM2 activity by the ribosomal protein L11. Cancer Cell 3:577-587 (Pubitemid 36808652)
41. Yao H, Feng Y, Zhou T, Wang J, Wang Z (2012) NMR studies of the interaction between human programmed cell death 5 and human p53. Biochemistry 51:2684-2693
42. Schon O, Friedler A, Freund S, Fersht AR (2004) Binding of p53-derived ligands to MDM2 induces a variety of long range conformational changes. J Mol Biol 336:197-202 (Pubitemid 38102341)
43. Meek DW (1994) Post-translational modification of p53. Semin Cancer Biol 5:203-210 (Pubitemid 124006730)